ARIX — Arix Bioscience Share News
0.000.00%
- £183.80m
- £82.85m
- £0.11m
- 29
- 34
- 90
- 48
REG-Arix Bioscience PLC Result of Annual General Meeting
AnnouncementREG-Arix Bioscience PLC Portfolio company Ensoma announces closing of Series B Extension
AnnouncementREG-Arix Bioscience PLC Unaudited NAV for April 2023
AnnouncementREG - Arix Bioscience Plc - Total Voting Rights
AnnouncementREG - Arix Bioscience Plc - Director/PDMR Shareholding
AnnouncementREG - Arix Bioscience Plc - Director/PDMR Shareholding
AnnouncementREG - Arix Bioscience Plc - Director/PDMR Shareholding
AnnouncementREG-Arix Bioscience PLC Arix Co-leads $50 Million Series B Financing for New Portfolio Company Evommune
AnnouncementREG-Arix Bioscience PLC Financial Results for the Year Ended 31 December 2022, Publication of Annual Report & Notice of AGM
AnnouncementREG-Arix Bioscience PLC Full Year results now to be released on 25 April 2023
AnnouncementREG-Arix Bioscience PLC Unaudited NAV for March 2023
AnnouncementREG-Arix Bioscience PLC Notice of Results and Investor Presentation
AnnouncementREG-Arix Bioscience PLC Portfolio company Harpoon Therapeutics announces closing of $25 million private placement
AnnouncementREG-Arix Bioscience PLC Unaudited NAV for February 2023
AnnouncementREG-Arix Bioscience PLC Portfolio company Disc Medicine announces $62.5 million financing
AnnouncementREG-Arix Bioscience PLC Director/PDMR Shareholding
AnnouncementREG-Arix Bioscience PLC Unaudited NAV for January 2023
AnnouncementREG-Arix Bioscience PLC Unaudited NAV for December 2022
AnnouncementREG-Arix Bioscience PLC Board Change
Announcement